These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 522718)

  • 1. The process of product selection in the medical instrument market.
    Hochberg HM
    Med Instrum; 1979; 13(6):344-6. PubMed ID: 522718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and recognition of consensus standards in US premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Mar; 10(2):13-7. PubMed ID: 10387610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; device tracking--FDA. Final rule; suspension of effective date; notification of status under the Safe Medical Devices Act; technical amendments.
    Fed Regist; 1993 Aug; 58(156):43442-51. PubMed ID: 10127886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assignment of agency component for review of premarket applications--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58754-8. PubMed ID: 10115697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
    Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new FDA combination products programme.
    Donawa M
    Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the US submisson process.
    Donawa M
    Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nightmare of FDA clearance/approval to market: perception or reality?
    Tylenda CA
    Technol Health Care; 1996 Sep; 4(3):259-67. PubMed ID: 8931236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment and management as related to evaluation of medical devices: a view from the FDA.
    Callahan TJ; Marlowe DE
    J Long Term Eff Med Implants; 1993; 3(4):269-76. PubMed ID: 10172029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working draft of the FDA GMP final rule (Part I).
    Donawa ME
    Med Device Technol; 1995 Oct; 6(8):13-22. PubMed ID: 10158125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe and effective medical devices--everyone's responsibility.
    Franke KA
    Gastroenterol Nurs; 1992 Apr; 14(5):245-8. PubMed ID: 1581379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences of new product development in the medical device industry.
    Dixon D; Brown A; Meenan BJ; Eatock J
    Med Device Technol; 2006 Apr; 17(3):20-2. PubMed ID: 16736659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA and the critical path to twenty-first-century medicine.
    Pitts PJ
    J Med Philos; 2008 Oct; 33(5):515-23. PubMed ID: 18840855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New US agent requirements.
    Donawa M
    Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; illustrative and designated lists for device tracking--FDA. Final rule and request for comments.
    Fed Regist; 1993 Aug; 58(156):43451-5. PubMed ID: 10171508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.